BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9851263)

  • 1. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera.
    Lackner KJ; Schlosser U; Lang B; Schmitz G
    Br J Rheumatol; 1998 Nov; 37(11):1164-71. PubMed ID: 9851263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis.
    Vittecoq O; Salle V; Jouen-Beades F; Krzanowska K; Ménard JF; Gayet A; Fardellone P; Tauveron P; Le Loët X; Tron F
    Rheumatology (Oxford); 2001 Oct; 40(10):1126-34. PubMed ID: 11600742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance].
    Yasuoka H; Sugano Y; Oka T; Watanabe C; Kaneko Y; Nojima T; Matsumura M; Fujii T; Mimori T
    Ryumachi; 1997 Jun; 37(3):458-66. PubMed ID: 9256029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis.
    Auger I; Roudier C; Guis S; Balandraud N; Roudier J
    Ann Rheum Dis; 2007 Dec; 66(12):1588-93. PubMed ID: 17324966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.
    Mimori T; Suganuma K; Tanami Y; Nojima T; Matsumura M; Fujii T; Yoshizawa T; Suzuki K; Akizuki M
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7267-71. PubMed ID: 7638179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of isotype-specific autoantibodies to calpastatin in sera from patients with rheumatic diseases using heat-treated HeLa cell extract as an antigen source for immunoblotting].
    Takada R; Matsumoto M; Yosida M; Nojima T; Hirakata M; Ohosone Y; Mimori T
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Aug; 21(4):150-8. PubMed ID: 9793376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against the protease inhibitor calpastatin: a new risk factor for venous thrombosis?
    Schlosser U; Lackner KJ; Scheckenhofer C; Spannagl M; Spengel FA; Hahn G; Lang B; Schmitz G
    Thromb Haemost; 1997 Jan; 77(1):11-3. PubMed ID: 9031441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpastatin autoantibodies: detection, epitope mapping, and development of a specific peptide ELISA.
    Schlosser U; Lackner KJ; Scheckenhofer C; Schmitz G
    Clin Chem; 1996 Aug; 42(8 Pt 1):1250-6. PubMed ID: 8697585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies directed against the amino-terminal domain I of human calpastatin (ACAST-DI Ab) in connective tissue diseases. High levels of ACAST-DI Ab are associated with vasculitis in lupus.
    Saulot V; Vittecoq O; Salle V; Drouot L; Legoedec J; Le Loët X; Godin M; Ducroix JP; Ménard JF; Tron F; Gilbert D
    J Autoimmun; 2002; 19(1-2):55-61. PubMed ID: 12367559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
    Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y
    J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.
    Després N; Talbot G; Plouffe B; Boire G; Ménard HA
    J Clin Invest; 1995 Apr; 95(4):1891-6. PubMed ID: 7706496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases.
    Kanazawa Y; Kaneshiro Y; Sawa M; Yasuoka H; Nojima T; Ohosone Y; Mimori T
    Mod Rheumatol; 2000 Mar; 10(1):38-44. PubMed ID: 24383532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
    Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
    Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factors from patients with rheumatoid arthritis react with beta 2-microglobulin.
    Williams RC; Malone CC; Tsuchiya N
    J Immunol; 1992 Aug; 149(3):1104-13. PubMed ID: 1378864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New autoantibodies in early rheumatoid arthritis.
    Charpin C; Arnoux F; Martin M; Toussirot E; Lambert N; Balandraud N; Wendling D; Diot E; Roudier J; Auger I
    Arthritis Res Ther; 2013 Jul; 15(4):R78. PubMed ID: 23886014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
    Lundberg K; Kinloch A; Fisher BA; Wegner N; Wait R; Charles P; Mikuls TR; Venables PJ
    Arthritis Rheum; 2008 Oct; 58(10):3009-19. PubMed ID: 18821669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N- or C-terminal biotinylation in autoantibody recognition of citrullin containing filaggrin epitope peptides in rheumatoid arthritis.
    Babos F; Szarka E; Nagy G; Majer Z; Sármay G; Magyar A; Hudecz F
    Bioconjug Chem; 2013 May; 24(5):817-27. PubMed ID: 23617702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis.
    Real-Fernández F; Pratesi F; Migliorini P; Rovero P
    Methods Mol Biol; 2019; 1901():221-228. PubMed ID: 30539581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis.
    Sakata M; Tsuruha JI; Masuko-Hongo K; Nakamura H; Matsui T; Sudo A; Nishioka K; Kato T
    J Rheumatol; 2001 Jul; 28(7):1492-5. PubMed ID: 11469452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.